NCT06194877 2025-04-20A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersMapKure, LLCPhase 1 Terminated13 enrolled